Clinical Trial Update: Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the efficacy and safety of ASCA101 for cancer-related cachexia. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Cancer

Drugs mentioned

• ASCA101

Snippet

Sponsor: MetaFines | Conditions: Cachexia; Cancer | Phase 2 | Status: NOT_YET_RECRUITING